Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Draper

Showing results (341-350 of 404) with videos related to

Pageof 41
Sort By:
NPJ Vaccines|January 6, 2024
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trialFrancisco J Martinez, Michael White, Micheline Guillotte-Blisnick, et al.
The Journal of Infectious Diseases|April 11, 2013
Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionAlexander D Douglas, Nick J Edwards, Christopher J A Duncan, et al.
Iscience|August 3, 2020
A Humanized Mouse Model for Plasmodium vivax to Test Interventions that Block Liver Stage to Blood Stage Transition and Blood Stage InfectionCarola Schäfer, Wanlapa Roobsoong, Niwat Kangwanrangsan, et al.
NPJ Vaccines|October 25, 2024
Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolatesLaty G Thiam, Kirsty McHugh, Aboubacar Ba, et al.
Biotechnology and Bioengineering|July 13, 2022
Production of a high purity, C-tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditionsEkta Mukhopadhyay, Florian Brod, Philip Angell-Manning, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Scientific Reports|April 24, 2013
The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessmentAnna L Goodman, Emily K Forbes, Andrew R Williams, et al.
Nature Communications|October 26, 2023
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccinationElena Mitsi, Mariana O Diniz, Jesús Reiné, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2013
Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5Alexander D Douglas, Andrew R Williams, Ellen Knuepfer, et al.
Infection and Immunity|August 18, 2010
New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1Anna L Goodman, C Epp, D Moss, et al.
Pageof 41

Showing results (341-350 of 404) with videos related to

Sort By:
Pageof 41
NPJ Vaccines|January 6, 2024
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trialFrancisco J Martinez, Michael White, Micheline Guillotte-Blisnick, et al.
The Journal of Infectious Diseases|April 11, 2013
Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionAlexander D Douglas, Nick J Edwards, Christopher J A Duncan, et al.
Iscience|August 3, 2020
A Humanized Mouse Model for Plasmodium vivax to Test Interventions that Block Liver Stage to Blood Stage Transition and Blood Stage InfectionCarola Schäfer, Wanlapa Roobsoong, Niwat Kangwanrangsan, et al.
NPJ Vaccines|October 25, 2024
Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolatesLaty G Thiam, Kirsty McHugh, Aboubacar Ba, et al.
Biotechnology and Bioengineering|July 13, 2022
Production of a high purity, C-tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditionsEkta Mukhopadhyay, Florian Brod, Philip Angell-Manning, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Scientific Reports|April 24, 2013
The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessmentAnna L Goodman, Emily K Forbes, Andrew R Williams, et al.
Nature Communications|October 26, 2023
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccinationElena Mitsi, Mariana O Diniz, Jesús Reiné, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 3, 2013
Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5Alexander D Douglas, Andrew R Williams, Ellen Knuepfer, et al.
Infection and Immunity|August 18, 2010
New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1Anna L Goodman, C Epp, D Moss, et al.
Pageof 41